

American Biomanufacturing Summit
Lunch & Learn
Roundtables
12:50 pm – 1:50 pm
Day 2
Table 1


Rahul Kaushik
Chief Technical Officer
Disc Medicine
What, how, when: navigating CMC considerations for programs on an accelerated approval pathway
Spots Remaining: 0
TABLE 2


Andy Lin
VP and Global Head, Individualized and Cell Therapy Development, Pharma Technical
Genentech
Enhancing the Development and Manufacturing of Individualized Cell Therapies
Spots Remaining: 0
TABLE 3


Andrew Wirths
SVP, Global Operations
AstraZeneca
Achieving Carbon Zero: AstraZeneca's Path to Sustainability in Manufacturing
Spots Remaining: 0
TABLE 4


Christopher Grail
SVP and Head, Global Pharma Engineering
Bayer


Danielle Golay
VP, Biologics and Cell Therapy Quality
Bayer
Synergistic Collaboration Between Production, Engineering and Quality as Important Success Factors In Manufacturing
Spots Remaining: 0
TABLE 5


Suki Toguchi
Chief of Staff
Gilead Sciences
Leading Digital Strategy: Driving Transformation Across Gilead’s Pharma Development and Manufacturing
Spots Remaining: 0
TABLE 6


Rakesh Kakkar
VP and Head, Manufacturing and Supply Vaccines, US
Sanofi
Driving Operational excellence, Quality and Compliance in Biomanufacturing
Spots Remaining: 0
TABLE 7


Keñya Edmondson
VP, Sterile Injectables Operations
Pfizer
Talent Development in Biopharma: Cultivating the Next Generation
Spots Remaining: 0
TABLE 8


Nooshafarin Sanaie
VP, Process and Analytical Development
Poseida Therapeutics
Scaling Allogeneic CAR-T Manufacturing: Overcoming Challenges and Driving Innovation
Spots Remaining: 1
TABLE 9


Kara Renai King
Platform Leader, Americas and China and Lead, Global Manufacturing Learning and Development
Zoetis
MEET THE SPEAKER
Spots Remaining: 0
TABLE 10


RJ Doornbos
VP, Quality Operating Systems and Services
Amgen
MEET THE SPEAKER
Spots Remaining: 0
TABLE 11


Ben Beneski
SVP and Chief Technical Officer
Allogene Therapeutics
MEET THE SPEAKER
Spots Remaining: 0